797 related articles for article (PubMed ID: 27765359)
21. Molecular mechanisms of cardiac electromechanical remodeling during Chagas disease: Role of TNF and TGF-β.
Cruz JS; Machado FS; Ropert C; Roman-Campos D
Trends Cardiovasc Med; 2017 Feb; 27(2):81-91. PubMed ID: 27622432
[TBL] [Abstract][Full Text] [Related]
22. NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease.
Dhiman M; Garg NJ
J Pathol; 2011 Dec; 225(4):583-96. PubMed ID: 21952987
[TBL] [Abstract][Full Text] [Related]
23. Chagas cardiomyopathy: The potential effect of benznidazole treatment on diastolic dysfunction and cardiac damage in dogs chronically infected with Trypanosoma cruzi.
Santos FM; Mazzeti AL; Caldas S; Gonçalves KR; Lima WG; Torres RM; Bahia MT
Acta Trop; 2016 Sep; 161():44-54. PubMed ID: 27215760
[TBL] [Abstract][Full Text] [Related]
24. Chagas disease: Present status of pathogenic mechanisms and chemotherapy.
Maya JD; Orellana M; Ferreira J; Kemmerling U; López-Muñoz R; Morello A
Biol Res; 2010; 43(3):323-31. PubMed ID: 21249304
[TBL] [Abstract][Full Text] [Related]
25. MyD88 activation in cardiomyocytes contributes to the heart immune response to acute Trypanosoma cruzi infection with no effect on local parasite control.
Santana DY; Salgado RM; Fevereiro M; Silva do Nascimento R; Fonseca R; Saraiva Câmara NO; Epiphanio S; Marinho CRF; Barreto-Chaves ML; D' Império-Lima MR; Álvarez JM
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006617. PubMed ID: 30067739
[TBL] [Abstract][Full Text] [Related]
26. Cardiomyocyte diffusible redox mediators control
Estrada D; Specker G; Martínez A; Dias PP; Hissa B; Andrade LO; Radi R; Piacenza L
Biochem J; 2018 Apr; 475(7):1235-1251. PubMed ID: 29438066
[TBL] [Abstract][Full Text] [Related]
27. Identification of host antioxidant effectors as thioridazine targets: Impact on cardiomyocytes infection and Trypanosoma cruzi-induced acute myocarditis.
Liz Belli Cassa Domingues E; Gonçalves-Santos E; Santana Caldas I; Vilela Gonçalves R; Caetano-da-Silva JE; Cardoso Santos E; Mól Pelinsari S; Figueiredo Diniz L; Dias Novaes R
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167264. PubMed ID: 38806073
[TBL] [Abstract][Full Text] [Related]
28. Administration of granulocyte colony-stimulating factor induces immunomodulation, recruitment of T regulatory cells, reduction of myocarditis and decrease of parasite load in a mouse model of chronic Chagas disease cardiomyopathy.
Vasconcelos JF; Souza BS; Lins TF; Garcia LM; Kaneto CM; Sampaio GP; de Alcântara AC; Meira CS; Macambira SG; Ribeiro-dos-Santos R; Soares MB
FASEB J; 2013 Dec; 27(12):4691-702. PubMed ID: 23964077
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
[TBL] [Abstract][Full Text] [Related]
30. Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
Carrillo I; Rabelo RAN; Barbosa C; Rates M; Fuentes-Retamal S; González-Herrera F; Guzmán-Rivera D; Quintero H; Kemmerling U; Castillo C; Machado FS; Díaz-Araya G; Maya JD
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009978. PubMed ID: 34784372
[TBL] [Abstract][Full Text] [Related]
31. LDL-Dependent Regulation of TNFα/PGE
Neuschäfer-Rube F; Schön T; Kahnt I; Püschel GP
Inflammation; 2023 Jun; 46(3):893-911. PubMed ID: 36598592
[TBL] [Abstract][Full Text] [Related]
32. Trypanosoma cruzi infection disrupts vinculin costameres in cardiomyocytes.
Melo TG; Almeida DS; de Meirelles Mde N; Pereira MC
Eur J Cell Biol; 2004 Oct; 83(10):531-40. PubMed ID: 15679099
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of Cardiac IL-10 and Downregulation of IFN-
da Silva MV; de Almeida VL; de Oliveira WD; Matos Cascudo NC; de Oliveira PG; da Silva CA; da Silva ACS; Dos Reis Monteiro MLG; Correa RRM; Oliveira MAP; Lino-Júnior RS; Celes MRN; Machado JR
Mediators Inflamm; 2018; 2018():3421897. PubMed ID: 30622430
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi persistence in the native heart is associated with high-grade myocarditis, but not with Chagas' disease reactivation after heart transplantation.
Benvenuti LA; Roggério A; Nishiya AS; Campos SV; Fiorelli AI; Levi JE
J Heart Lung Transplant; 2014 Jul; 33(7):698-703. PubMed ID: 24675024
[TBL] [Abstract][Full Text] [Related]
35. Curcumin treatment provides protection against Trypanosoma cruzi infection.
Nagajyothi F; Zhao D; Weiss LM; Tanowitz HB
Parasitol Res; 2012 Jun; 110(6):2491-9. PubMed ID: 22215192
[TBL] [Abstract][Full Text] [Related]
36. Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease.
Mukherjee S; Machado FS; Huang H; Oz HS; Jelicks LA; Prado CM; Koba W; Fine EJ; Zhao D; Factor SM; Collado JE; Weiss LM; Tanowitz HB; Ashton AW
PLoS One; 2011 Feb; 6(2):e16959. PubMed ID: 21347238
[TBL] [Abstract][Full Text] [Related]
37. Altered Cardiomyocyte Function and Trypanosoma cruzi Persistence in Chagas Disease.
Cruz JS; Santos-Miranda A; Sales-Junior PA; Monti-Rocha R; Campos PP; Machado FS; Roman-Campos D
Am J Trop Med Hyg; 2016 May; 94(5):1028-33. PubMed ID: 26976879
[TBL] [Abstract][Full Text] [Related]
38. Mice with Genetic Deletion of Group VIA Phospholipase A2β Exhibit Impaired Macrophage Function and Increased Parasite Load in Trypanosoma cruzi-Induced Myocarditis.
Sharma J; Blase JR; Hoft DF; Marentette JO; Turk J; McHowat J
Infect Immun; 2016 Apr; 84(4):1137-1142. PubMed ID: 26857573
[TBL] [Abstract][Full Text] [Related]
39. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy.
Andrade D; Serra R; Svensjö E; Lima AP; Ramos ES; Fortes FS; Morandini AC; Morandi V; Soeiro Mde N; Tanowitz HB; Scharfstein J
Br J Pharmacol; 2012 Mar; 165(5):1333-47. PubMed ID: 21797847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
